C. Kresge

Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator.

M. Dowsett, D. Hayes, D. Decker, 2012, Journal of oncology practice.

Study of Sexual Functioning Determinants in Breast Cancer Survivors

D. Zakalik, D. Decker, Veronica B. Decker, 2005, The breast journal.

High‐Dose Ketoconazole Therapy in Patients with Metastatic Prostate Cancer

D. Decker, M. al-Sarraf, C. Kresge, 1986, American journal of clinical oncology.

Phase 11 study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation

D. Decker, H. Wilner, C. Kresge, 1985, Journal of Neuro-Oncology.

A randomized trial of a low-fat dietary intervention in women at high risk for breast cancer.

S. Martino, M. Simon, F. Valeriote, 1997, Nutrition and cancer.

Serum interleukin 2 (IL-2) levels and prolactin bioactive/radioimmunoassay ratios of women at risk for breast cancer.

S. Martino, M. Alonso, C. Kresge, 1989, European journal of cancer & clinical oncology.

Phase II evaluation of Aclacinomycin-A in advanced ovarian carcinoma

S. Martino, D. Decker, H. Hynes, 1987, Investigational new drugs.